1. Home
  2. GDTC vs PCLA Comparison

GDTC vs PCLA Comparison

Compare GDTC & PCLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CytoMed Therapeutics Limited

GDTC

CytoMed Therapeutics Limited

HOLD

Current Price

$1.66

Market Cap

24.8M

Sector

Health Care

ML Signal

HOLD

Logo PicoCELA Inc. American Depositary Shares

PCLA

PicoCELA Inc. American Depositary Shares

HOLD

Current Price

$0.25

Market Cap

18.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
GDTC
PCLA
Founded
2018
2008
Country
Singapore
Japan
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Building Products
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
24.8M
18.6M
IPO Year
2023
2025

Fundamental Metrics

Financial Performance
Metric
GDTC
PCLA
Price
$1.66
$0.25
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
78.6K
741.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$573,193.00
$5,065,197.00
Revenue This Year
$5.37
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
63.03
5.26
52 Week Low
$1.50
$0.25
52 Week High
$4.05
$9.80

Technical Indicators

Market Signals
Indicator
GDTC
PCLA
Relative Strength Index (RSI) 40.26 27.17
Support Level $1.71 $0.27
Resistance Level $2.12 $0.33
Average True Range (ATR) 0.12 0.02
MACD -0.01 0.00
Stochastic Oscillator 25.81 6.14

Price Performance

Historical Comparison
GDTC
PCLA

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

About PCLA PicoCELA Inc. American Depositary Shares

PicoCELA Inc specializes in manufacturing, installing, and servicing enterprise wireless mesh solutions. The company generates revenue from two main sources: product equipment sales, and Software as a Service (SaaS) and maintenance services. The company develops the PCWL series of mesh Wi-Fi access points, which utilize its proprietary PicoCELA Backhaul Engine (PBE) technology to enable wireless communication. The company outsources manufacturing and sells these devices directly to customers through distributors. Additionally, the company offers a cloud portal service in a SaaS model, allowing users to monitor connectivity and traffic at their access points. This platform also supports the installation of proprietary edge-computing software into the devices.

Share on Social Networks: